- In September 2023, Quanta announced its submission for FDA 510(k) approval for the home use of its Quanta Dialysis System. This submission aims to expand the system's accessibility by allowing patients to perform dialysis treatments at home. If approved, the Quanta Dialysis System will offer greater flexibility and independence for patients, reducing the need for frequent hospital visits. The system is designed to provide effective, portable, and user-friendly dialysis, enhancing patient comfort and quality of life while lowering healthcare costs by enabling more home-based treatments. This move is expected to improve the accessibility and convenience of dialysis therapy
- In August 2023, Fresenius Medical Care announced the FDA clearance of its Versi HD hemodialysis system with the GuideMe software. This innovation aims to enhance the dialysis process by providing real-time guidance and support for healthcare providers and patients. The GuideMe software offers step-by-step instructions for dialysis procedures, making the system easier to use, especially in home settings. This clearance will improve treatment safety, reduce the learning curve for new users, and increase patient confidence in managing their dialysis at home. It is expected to elevate the quality of care and enhance overall treatment outcomes
- In March 2022, Nipro introduced its SURDIAL DX hemodialysis system to the U.S. market. This advanced system was developed to improve the dialysis treatment experience for both patients and clinicians. The SURDIAL DX offers enhanced performance and a user-friendly interface, aiming to provide better outcomes for patients by reducing treatment times and improving overall efficiency. Nipro is inviting dialysis clinics nationwide to experience the system, which is designed to address the challenges faced during traditional dialysis procedures. This introduction is expected to elevate patient care and optimize dialysis treatments across the U.S. healthcare system
